Post-approval studies (Phase 4)Ended earlyNCT03277183
What this trial is testing
Frequent, Low-Dose Erythropoietin A Mechanistic Approach to Mitigate Adverse Cardiovascular Effects of Erythropoietin
Who this might be right for
AnemiaCKDAtherosclerosis+1 more
VA Office of Research and Development 5